John Antonakis is a Professor of Organizational Behavior at the University of Lausanne’s Faculty of Business and Economics (HEC). He also serves as a Visiting Scholar at ISM. His research focuses on charisma, leadership development, crisis management, and research methodology. Antonakis has secured over $2.45 million in research funding and has been recognized as a Clarivate-Web of Science Highly Cited Researcher (2019) and ranked in the world’s top 2% researchers by PLOS Biology (2020). His work spans prestigious journals like Science, Nature Human Behavior, and Academy of Management Journal. Notable contributions include studies on charismatic leadership’s economic impact, crisis rhetoric effects, and methodological critiques of statistical techniques. Antonakis has held editorial roles including Editor-in-Chief of The Leadership Quarterly and served on top journal boards. Media outlets such as the New York Times and BBC frequently cite his research. Key Research Themes: Charismatic leadership, crisis leadership, leadership measurement, and statistical methodology. Recent Focus: Deep learning applications in leadership detection, gender gaps in venture funding, and pandemic leadership strategies. His publications emphasize rigorous experimental design and transparency in research practices, contributing to methodological advancements in organizational studies.
Yan Huang is an Associate Research Scientist in the Department of Comparative Medicine at Yale University's School of Medicine. He holds a PhD in Medicine from Hunan Medical University (1998) and has focused his research on cardiovascular diseases, stem cell biology, and regenerative medicine. His work includes developing transgene-free induced pluripotent stem cell (iPSC) models for vascular tissue engineering and exploring mechanisms underlying cardiac pathologies like supravalvular aortic stenosis and heart failure. Collaborations with researchers like Yibing Qyang and George Tellides highlight his team-based approach to translational research. Key research themes include vascular endothelial cell engineering, elastin assembly in cardiovascular tissues, and molecular pathways regulating cardiac hypertrophy. Huang's contributions span peer-reviewed articles in high-impact journals such as Acta Biomaterialia and Arteriosclerosis Thrombosis and Vascular Biology . His publications emphasize translational applications, including therapeutic cell patches for heart disease and zinc-finger protein-based gene therapies. No awards or grants are explicitly listed, but his work has been supported by funding such as a $2M federal grant for stem cell-based therapies (2019). He collaborates with interdisciplinary teams across cardiology, bioengineering, and molecular biology, contributing to both basic science and clinical applications in regenerative medicine.
Dr. Jie Liu is a Lecturer at the University of Sydney's Sydney Medical School within the Faculty of Medicine and Health. He is affiliated with the Charles Perkins Centre, focusing on themes like Obesity, Diabetes, and Cardiovascular Disease. His research integrates molecular biology, nanotechnology, and biomedical imaging to explore cardiovascular pathophysiology and cellular mechanisms. Research interests include cardiac electrophysiology, fluorescent probe development, and nanomaterials for medical applications. Key projects involve sinoatrial node function, nucleolar RNA dynamics, and photodynamic therapy using advanced imaging techniques. Dr. Liu's work bridges basic science and translational medicine, addressing challenges in cardiology and cell biology. Recent publications highlight innovations in three-photon imaging, nucleophagy regulation, and biological pacemaker engineering. His studies often employ cutting-edge techniques like single-cell RNA sequencing and super-resolution microscopy. Collaborations span cardiology, materials science, and bioengineering, reflecting interdisciplinary research priorities. No explicit scientific awards are listed, though his prolific publication record indicates recognition in the field. His work contributes to understanding aging effects on cardiac rhythm, nanotechnology-driven diagnostics, and targeted therapy development.
Bruce G. Allen is a Professor in the Department of Biochemistry and Molecular Medicine at Université de Montréal's Faculty of Medicine and researcher at the Montreal Heart Institute. His laboratory investigates nuclear G-protein coupled receptor signaling in cardiac cells, p38 MAP kinase pathways in heart hypertrophy, and molecular mechanisms of cardiovascular disease. Research themes focus on nuclear GPCR function in cardiomyocytes, endothelin/β-adrenergic receptor signaling, and p38 MAP kinase regulation during cardiac remodeling. His team employs proteomic approaches to study signaling complexes and develops models for cardiac fibrosis and hypertrophy. Recent publications examine intracellular angiotensin receptors, MK2/MK3 kinases in myocardial infarction, and transglutaminase implications in heart pathology. Dr. Allen's work bridges molecular pharmacology and cardiac pathophysiology to identify therapeutic targets.
Anssi Laaksonen is an Associate Professor at the Department of Construction Technology, Concrete and Bridge Structures at Tampere University. His research focuses on structural engineering, particularly bridge design, concrete behavior under extreme conditions, and infrastructure sustainability. He has extensive experience in experimental testing and computational modeling of civil engineering systems. Key areas of expertise include: Structural assessment of bridges and concrete elements Failure analysis of post-tensioned systems Material characterization and testing Design optimization of energy-efficient structures His work integrates advanced numerical methods with physical experimentation, addressing challenges in structural redundancy, material degradation, and long-term performance. Notable projects include long-term monitoring of the Haavistonjoki Bridge and investigations into energy piles and tied-arch bridge systems. Research trends in his publications emphasize: Enhancing structural resilience through innovative joint designs Improving material utilization via refined truss models Addressing emerging issues like overloaded axle impacts on railway structures His contributions have advanced understanding of tendon behavior, lap splice efficiency, and composite action in precast systems. While no awards are explicitly listed, his prolific publication record reflects sustained academic impact.
Klaas Bax serves as a Researcher in the Department of Pediatric Surgery at Erasmus University Rotterdam's Faculty of Medicine, affiliated with Erasmus MC. His academic profile spans cardiovascular surgery, gastrointestinal reconstruction, and laparoscopic innovation with 44 research outputs including 27 articles and 17 book chapters. His research centers on Cardiovascular Pathophysiology , investigating molecular mechanisms like fibulin-4's role in cardiac hypertrophy and heart failure, and Surgical Innovation in pediatric gastrointestinal procedures. Key projects include optimizing laparoscopic working space through CT imaging of abdominal pressure dynamics in porcine models, examining factors like neuromuscular blockade, body size constraints, and bowel preparation protocols. His fingerprint reveals 100% concentration in Heart Ventricle Hypertrophy, Congestive Heart Failure, Fibulin, Intestine Preparation, and Laparoscopic Surgery. Publications demonstrate a clear trajectory from foundational surgical techniques (2013-2015 studies on laparoscopy optimization) toward translational molecular cardiology (2025 fibulin-4 study). This evolution highlights integration of basic science with clinical surgical applications, particularly in pressure-overload cardiac conditions and congenital gastrointestinal reconstruction. Dr. Bax has supervised 2 graduate students as indicated by institutional records, with collaborative networks spanning pharmacology, toxicology, and surgical specialties. His work maintains strong connections to clinical practice through Erasmus MC's Pediatric Surgery department while advancing experimental methodologies in porcine models.
Robert Koza is a Faculty Scientist II at the MaineHealth Institute for Research and a faculty member of the University of Maine's Graduate School of Biomedical Science and Engineering. His research centers on molecular mechanisms of obesity and metabolic disease, with emphasis on epigenetic pathways and thermogenic energy expenditure. Education: BS in Biology, North Adams State College, 1984 MS in Biochemistry, University of New Hampshire, 1986 PhD in Biochemistry, University of New Hampshire, 1989 Research Focus: Dr. Koza investigates non-genetic molecular drivers of obesity through his Epigenetics and Obesity Laboratory. Key work includes identifying the MEST gene's role in lipid storage and characterizing UCP1-independent thermogenesis. His research bridges epigenetics , adipose biology , and metabolic therapeutics , with implications for diabetes and cardiovascular disease. Publication Trends: Analysis of his recent work reveals consistent exploration of adipose tissue regulation, featuring genes like MEST and CTHRC1 , dietary interventions (methionine restriction), and alternative thermogenic pathways. Publications span molecular mechanisms to translational models, targeting obesity treatment strategies. Leadership: He directs the MMCRI Summer Student Research Program and chairs the MMC Scientific Review Committee. Dr. Koza has extensive grant review experience for NIH (NIDDK, NIEHS), DOD, and NSERC (Canada). Laboratory: The Epigenetics and Obesity Laboratory employs mouse models to study how genetic predisposition and environmental factors interact in metabolic disease, with current projects focusing on energy-expending mechanisms for obesity therapeutics.
Dennis M Abraham is an Assistant Professor of Medicine at the Duke University School of Medicine , specializing in Cardiology . His research focuses on molecular mechanisms of cardiac dysfunction, particularly in chronic kidney disease, pressure overload, and space radiation contexts. Current Appointments: 2021-Present Previous Appointments: 2015-2020 Professional Training: Internal Medicine Residency (2003-2005) and Internship (2002-2003) at Icahn School of Medicine at Mount Sinai Research Interests include: Cardiac hypertrophy and fibrosis mechanisms Role of deubiquitinases (USP20) in cardiac receptor regulation Space radiation-induced cardiovascular degeneration Fibroblast growth factor signaling in CKD-cardiovascular interaction Ion channel modulation of cardiac remodeling Scientific Contributions span 15 years, with recent work emphasizing fibroblast growth factor pathways , deubiquitinase regulation , and space radiation effects . His publications explore cardiovascular disease mechanisms across diverse contexts from chronic kidney disease to addiction biology. Grants include NIH funding (2021-2025) for GPCR regulation in cardiac disease and NASA grants (2016-2022) studying space radiation effects.
Bijoy Kumar Kundu is an Associate Professor in the Department of Radiology and Medical Imaging and the Department of Biomedical Engineering at the University of Virginia. He holds a PhD in Physics from the Bhabha Atomic Research Center, India, and completed postdoctoral work at the Indian Institute of Technology and UVA. His primary affiliation is within the School of Medicine, specifically in the Cardiovascular Research Center. Dr. Kundu's research focuses on developing novel PET imaging techniques to study metabolic and cardiovascular processes. Key areas include quantifying myocardial glucose and fatty acid metabolism in rodent models of heart disease, optimizing PET imaging for human brain and breast lesions, and applying machine learning for image analysis. His lab is funded by NIH grants, collaborating with institutions like the University of Texas and Spain’s Oncovision Inc. His work addresses metabolic remodeling in hypertension-induced left ventricular hypertrophy, brain abnormalities via FDG PET, and breast lesion segmentation using neural networks. Notable projects include noninvasive detection of early metabolic changes in cardiac diseases and advancements in PET quantification methods to correct partial volume and spill-over effects.
Johannes Lagethon Bjørnstad is an Associate Professor at the Department of Cardiothoracic Surgery, University of Oslo. He is also a Consultant Surgeon at Oslo University Hospital (OUH) with a focus on adult cardiac surgery and valve interventions. Education: M.D. from University of Bergen (1999) Ph.D. from University of Oslo (2011) Research Interests: Bjørnstad's work centers on myocardial remodeling and reverse remodeling mechanisms in the heart, particularly in relation to aortic stenosis and pressure overload. He investigates how extracellular matrix changes, TGF-β/SMAD signaling pathways, and anticoagulant therapies impact cardiac function and recovery. His studies often combine experimental models with clinical data from national registries. Article Trends: His recent publications (2022-2024) focus on anticoagulant management during cardiac emergencies, while earlier work (2012-2015) explores molecular mechanisms in heart failure and reverse remodeling. Key themes include cardiac surgery , extracellular matrix dynamics , and novel anticoagulant therapies . Full Description: Bjørnstad is a physician-scientist bridging clinical practice and translational research. His Ph.D. thesis (2011) introduced a mouse model for studying reverse remodeling, revealing early extracellular matrix changes. He has contributed to understanding how collagen isoforms, proteoglycans (like lumican and decorin), and cytokines (GDF-15, endothelin-1) regulate cardiac recovery. Clinical studies examine operative survival rates, post-surgery rehabilitation, and gender/age disparities in cardiac outcomes. Collaborations span institutions like Oslo University Hospital, University of Bergen, and University of Oslo. Current projects include anticoagulant removal techniques during emergencies and long-term registry analysis of aortic disease outcomes.
Ingrid van der Pluijm is an Associate Professor at Erasmus MC , affiliated with the Department of Molecular Genetics. Her research spans DNA repair mechanisms, vascular biology, cardiovascular diseases, and aging, with recent work focusing on dietary restriction, cardiac fibulin-4, and stem cell-derived cardiomyocytes. Research Interests include DNA damage response in progeroid models, vascular smooth muscle cell dysfunction, and molecular pathways underlying heart failure. Her work intersects molecular genetics and translational medicine, utilizing mouse models to study aging-related pathologies. Scientific Contributions highlight her role in 66 research outputs, including studies on: Modulating the cGAS-STING pathway in vascular aging Cardiac fibulin-4 as a protective agent in heart failure Stem cell-derived cardiomyocyte differentiation protocols Social frailty indices in aging mice Current collaborations involve institutions like the University of Minnesota, C57BL/6 mouse models, and interdisciplinary teams in molecular imaging and cell biology.
Xupei Huang, M.D., Ph.D. , is a Professor in Biomedical Science at the Charles E. Schmidt College of Medicine, Florida Atlantic University (FAU) . He has been affiliated with FAU since 2001 and previously held a Research Assistant Professor position at Texas A&M University (1996-2001). Huang earned his M.D. from Nanjing Medical University (1985) and Ph.D. in Biochemistry from University of Paris XII (1992). Research Focus: Mechanisms and treatment of cardiomyopathies and heart failure, with expertise in intracellular signaling, gene regulation, and transgenic animal models. Key Contributions: 80+ peer-reviewed papers on cardiac troponin mutations, epigenetic modifications, and pharmacological interventions like green tea catechins. Teaching: Leads the Cardiovascular System curriculum for medical students. Editorial Role: Associate Editor for the journal Cardiology . Article Trends: Recent work spans epigenetic mechanisms (histone acetylation, methylation) in cardiomyopathy, translational therapies (EGCG, sulindac derivatives), and genetic mouse models of restrictive cardiomyopathy. His lab explores oxidative stress pathways , contractile protein dynamics , and nuclear roles of cardiac proteins like troponin I. Labs & Collaborations: Huang’s research group at FAU collaborates on pediatric heart disease translational studies and investigates cardiac gene therapies using AAV vectors.
Nancy Lam is an Associate Professor of Management in the School of Economics and Business Administration (SEBA) at Saint Mary’s College of California , where she also serves as Department Chair of the Organizations and Responsible Business program and Director of the Executive Doctorate of Business Administration. She holds the endowed Guyette Professorship of Responsible Business and previously taught at Keck Graduate Institute (2009–2010). Education PhD in Organizational Behavior, New York University, 2009 MPhil in Management, New York University, 2006 BA, University of California, Berkeley Research Focus Dr. Lam’s scholarship centers on how ideas, information and innovation move through organizational hierarchies . One stream dissects voice and silence as multi-level, multi-actor processes, revealing when employees choose to speak up or stay quiet and how their messages are amplified or stifled by managers. A complementary line explores power’s influence on perception and evaluation , uncovering how authority shapes interpretation of events and communication. She also investigates creative pedagogy , leveraging virtual worlds and experiential projects to enhance business student engagement. Across more than 15 peer-reviewed articles and conference presentations since 2008, her work integrates organizational behavior, behavioral economics, and educational innovation , consistently highlighting the intersection of individual agency and structural constraints. Honors & Awards Outstanding Paper (Management), Global Conference on Business & Finance (2018) Outstanding Service Award, SEBA (2018) Outstanding Paper, International Conference on Business & Innovation (2017) Outstanding Research Award, SEBA (2016) Guyette Responsible Leadership Endowed Professorship (2014–present) SEBA Outstanding Teaching Award (2014) SMC Alumni-Faculty Fellowship Grant (2016) SEBA Teaching Innovation Grant (2012–2013) Best Paper (Management), American Business Research Conference (2011) Outstanding Empirical Paper Award, Eastern Academy of Management (2008) Showcase Symposium Chair, Academy of Management (2008) Teaching & Program Leadership Dr. Lam directs the Executive DBA program and chairs the Organizations & Responsible Business area, mentoring doctoral students and designing cutting-edge curricula. She teaches courses on Creativity & Innovation, Organizational Behavior, Managing Contemporary Organizations , and a popular Jan-Term course on Creativity , consistently integrating experiential and technology-enhanced methods. Labs & Teams While no formal lab is listed, she leads the Executive Doctorate of Business Administration cohort and collaborates with interdisciplinary faculty and doctoral researchers under the umbrella of SEBA’s Organizations and Responsible Business program.
Ida Gjervold Lunde is an Adjunct Professor at the Department of Cardiology, University of Oslo. Her research focuses on molecular mechanisms underlying cardiac fibrosis, extracellular matrix remodeling, and heart failure. She collaborates with the Cardiovascular Research Group (CRG) and Oslo-CCHR Lab, investigating therapeutic targets for cardiomyopathy and myocardial dysfunction. Her work explores proteoglycans (e.g., syndecan-4, lumican), signaling pathways (TGFβ, calcineurin-NFAT), and mechanical stress responses in cardiac tissue. Key interests include genetic models of heart disease, exercise-induced cardioprotection, and extracellular enzyme inhibition to prevent fibrosis. Recent publications (2022-2024) emphasize reverse myocardial remodeling, t-tubule dynamics in cardiomyocytes, and genetic variants in dilated cardiomyopathy. Her studies utilize preclinical models to bridge molecular discoveries with clinical applications in heart failure management. She mentors through collaborative projects but no formal student advisees are listed. No awards or grants are detailed in the provided text.
Samuel Wall serves as Chief Research Scientist and Research Professor in the Department of Computational Physiology at Simula Research Laboratory. His work focuses on developing computational models to understand cardiac electromechanics, with particular emphasis on stem cell-derived cardiomyocytes and personalized heart modeling approaches. His research interests span computational cardiac physiology, mechano-electric feedback mechanisms, stem cell-derived cardiomyocyte modeling, and drug response prediction. Wall's work integrates advanced computational methods with experimental cardiac physiology to create in-silico tools for evaluating cardiac function, tissue engineering applications, and drug effects. His research has significant implications for understanding arrhythmia mechanisms, cardiac remodeling, and developing more accurate preclinical drug testing platforms. Analysis of Wall's recent publications reveals a strong trend toward integrating computational modeling with microphysiological systems, particularly using human-induced pluripotent stem cell-derived cardiomyocytes. His work increasingly focuses on creating in-silico augmented platforms that combine experimental measurements with computational analysis to improve drug response prediction and understand fundamental cardiac mechanisms. The research spans multiple scales from sub-cellular mechanics to whole-organ function. Wall maintains active collaborations with leading institutions in cardiac modeling and biomedical engineering. His work frequently appears in high-impact journals spanning computational science, physiology, and biomedical engineering fields.
